NCCN Patient Webinar: Early and Locally Advanced Non-Small Cell Lung Cancer
Experts provide information and answer questions about early and locally advanced non-small cell lung cancer to help patients and caregivers compare, discuss, and select treatment options with their doctor. See list below for topics discussed. Please note that this is a not an accredited activity.
Topics Discussed:
0:00 - Welcome and Introductions
2:02 - Lung Cancer Screening
8:02 - Staging
12:25 - Local Treatments
19:13 - Induction and Adjuvant Therapy
30:04 - Patient Perspective and Lessons Learned from a Non-Small Cell Lung Cancer Survivor
43:43 - Question and Answer Session
1:23:33 - Closing Remarks
Question and Answer Session:
44:28 - What do you want the doctors to know from a patient perspective?
46:55 - Views on role of immunotherapies in NSCLC
49:58 - How long until we start to see immunotherapy following surgery?
50:32 - Oncologist says biopsy of the lymph node is not an option for me. How should I proceed?
52:17 - When is it a good time to seek a clinical trial?
56:22 - Views on systemic therapy after surgery
59:32 - Advice on getting a second opinion?
1:03:04 - Recovery after surgery
1:05:09 - Speak about the stigma associated with lung cancer
1:08:48 - Prognosis and Follow up
1:11:33 - Is a wedge resection considered the same as a biopsy of the lung?
1:12:41 - Some oncologists and some hospitals test for mutations even in early stage lung cancers. If this was not tested in 2019 for early stage, is it of any value to get the tumor retested now for additional mutations?
1:14:10 - How often in your practice does adjuvant therapy happen with early stage tumors?
1:15:09 - Is it common now to use Pembrolizumab immunotherapy for certain types of lung cancers?
1:15:48 - Impact of exercise before surgery
1:16:56 - Metastatic disease after treatment
1:19:07 - What is the best way to have insurance companies understand the challenge of patients with lung cancer?
1:21:40 - Are you ever out of the woods with early stage lung cancer? Can it come back after many years?
The Patient Webinars: Early and Locally Advanced Non-Small Cell Lung Cancer in September and October 2021. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Non-Small Cell Lung Cancer - Early and Locally Advanced. (https://www.nccn.org/patientre....sources/patient-reso
The NCCN Guidelines for Patients (http://nccn.org/patientguidelines) are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.
NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.
Supporters:
This webinar program is supported through the NCCN Foundation by a contribution from our corporate supporter AstraZeneca.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.
Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCN....video?sub_confirmati
Connect with us!
Twitter: https://twitter.com/NCCN
LinkedIn: https://www.linkedin.com/company/nccn/
Facebook: https://www.facebook.com/NCCNorg
Instagram: https://www.instagram.com/NCCNorg/
-
Category
No comments found